GO FUND IT NOW

INDIANA UNIVERSITY INDIANAPOLIS

PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life?

PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life? is a funding opportunity from INDIANA UNIVERSITY INDIANAPOLIS, up to 383683, closing February 28, 2027.

Funder
INDIANA UNIVERSITY INDIANAPOLIS
Funding
383683
Deadline
Feb 28, 2027
(212d left)

Overview

Project Summary/Abstract The 68Ga-P16-093 radiopharmaceutical is an investigational agent that targets prostate specific membrane antigen (PSMA), which is highly expressed in most prostate cancers. PSMA-PET has not been validated as a tool for guiding surgical resection of primary prostate cancer. The objective of…

PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life? | Go Fund It Now